Renal-dose dopamine: Myth or ally in the treatment of acute renal failure?

Shekar P. Kumar, Vincent L. Sorrell

Research output: Contribution to journalReview articlepeer-review


Dopamine is an inotropic agent that has vasodilatory effects at low doses. It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is being widely used in these situations. Does dopamine have a beneficial effect in acute renal failure? Numerous studies in animals and a few in humans using low-dose dopamine have been reported. In this review, the authors summarize the literature and discuss the basis of this practice, which should be considered more of a myth than an ally for this purpose.

Original languageEnglish
Pages (from-to)413-415
Number of pages3
JournalCardiovascular Reviews and Reports
Issue number8
StatePublished - Aug 1 2003

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Renal-dose dopamine: Myth or ally in the treatment of acute renal failure?'. Together they form a unique fingerprint.

Cite this